Notes: Over the last several years, multiple randomized multi-center
trials have investigated the safety and efficacy of oral anticoagulant
therapy for primary stroke prevention in AF patients (4–8).
The target range for the intensity of anticoagulation and
the use of aspirin varied between trials. The international
normalized ratio (INR) range recommend by the Fourth American
College of Chest Physicians Consensus Conference on Antithrombotic
Therapy is also shown.
The information in this
web site is not a substitute for medical advice or treatment.
Consultation with your doctor or health care professional is recommended.